Nova is trading -4.15% at $362.11 in pre-market on October 8, reportedly after Citi cut its rating from Buy to Neutral and its price target from $550 to $415.
- A Zacks Research downgrade in the prior session added to analyst pressure.
- Broader weakness may also be contributing: the Nasdaq fell 0.82% and the S&P 500 fell 0.58%. No new company announcement was identified.